Decline in frequent otitis media tied to PCV7.
After routine administration of the seven-valent pneumococcal conjugate vaccine began in mid-2000, the frequency of otitis media and pressure-equalizing tube insertions among children in Tennessee and New York born between 2000 and 2001 decreased significantly, compared with children born between 1998 and 1999, results from a large birth cohort...

JNC-7 spells big gains in blood pressure control.
CHICAGO -- Hypertension control has improved markedly in the United States since spring of 2003--and the JNC-7 guidelines deserve most of the credit, James Jackson, Pharm. D., said at the annual scientific sessions of the American Heart Association. The improvement in blood pressure control since release of...

OM, PET insertions down since PCV7.
After the routine administration of the seven-valent pneumococcal conjugate vaccine began in mid-2000, the frequency of otitis media and pressure-equalizing tube (PET) insertions in children in Tennessee and New York born between 2000 and 2001 decreased significantly, compared with children born between 1998 and 1999, data from a large...

Gentiva Health Services Schedules 2Q Earnings Call and Web Cast.
HEALTH AND BEAUTY CLOSE-UP-18 July 2007-Gentiva Health Services Schedules 2Q Earnings Call and Web Cast(C)2007 - CloseUpMedia - newsdesk@closeupmedia.com Gentiva Health Services, a national provider of comprehensive home health and related services, announced that it has scheduled a conference call and web cast on Wednesday, August 1,...

Menactra appears to be reaching target teens.
KANSAS CITY, MO. -- The strategy of immunizing all children at the 11- to 12-year preadolescent visit and those entering high school with the new meningococcal conjugate vaccine appears to be working, according to preliminary Centers for Disease Control and Prevention data. Uptake of Menactra vaccine was...

RotaTeq not tied to intussusception.
Atlanta -- The number of intussusception cases following administration of the current rotavirus vaccine thus far does not exceed the expected background rate, Dr. Manish Patel reported at a meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices. Approximately 3.6 million doses...

Warner Chilcott and Watson Pharmaceuticals Announce Launch of Zenchent(TM).
FAJARDO, Puerto Rico and CORONA, Calif., Jan. 29 /PRNewswire/ -- Warner Chilcott Company, Inc. and Watson Pharmaceuticals, Inc. announced today that under a supply agreement between Warner Chilcott and Watson Pharma, Inc., Watson has launched Zenchent(TM) (norethindrone and ethinyl estradiol tablets USP), the generic version of Warner Chilcott's oral...

Warner Chilcott Reduces Interest Rate on Existing Facility.
HAMILTON, Bermuda, Feb. 1 /PRNewswire-FirstCall/ -- Warner Chilcott Limited announced today the completion of an amendment to its credit agreement dated January 18, 2005. Effective immediately, the interest rates on the Company's term loans under the credit agreement were reduced by .25% to LIBOR plus 2.00% for LIBOR rate...

HMS Holdings Corp. to Present at UBS Global Healthcare Services Conference on February 13, 2007.
NEW YORK, Feb. 5 /PRNewswire-FirstCall/ -- HMS Holdings Corp. will be presenting to the investment community on Tuesday, February 13, 2007 at 9:00am Eastern Time at the 2007 UBS Global Healthcare Services Conference taking place at the Grand Hyatt New York in New York City. (Logo: http://www.newscom.com/cgi-bin/prnh/20030304/NYTU172LOGO...

Warner Chilcott and Foamix Collaborate on Gynecologic Foam Product.
FAJARDO, Puerto Rico and NESS ZIONA, Israel, Jan. 22 /PRNewswire/ -- Warner Chilcott Company, Inc. and Foamix Ltd. announced today that the two companies have signed an agreement to jointly develop a gynecologic foam. Under the terms of this agreement, Foamix will be responsible for developing the foam formulations...